Fuss Brands Corp

OTC: FBDS · Healthcare · Medical - Pharmaceuticals

PublicHQ New York, NY · New YorkCIK 0000926844Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ 12GM —SS 40

v0.1 · 25/100 weight · pillars only

↑ listing tenure, market scale · ↓ workforce scale, disclosure history

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$2.8M

Employees

Market cap

$2.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02020

Net income-$2.8M-$2.8M2024

Operating income-$2.8M-$2.8M2024

Total assets$228.2k$228.2k2024

Liabilities$915.5k$915.5k2024

Equity-$687.3k-$687.3k2024

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Fuss Brands Corp booked $0 in FY2020 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Lifeline Biotechnologies, Inc.——Tenon Medical, Inc.35D Synergy CHC Corp.35D Healthcare Triangle, Inc.40D

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B60C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A American Express Company$41.3B78B+Citigroup Inc.$85.2B56C

Key facts

CEOCheskel Meisels

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersNew York, NY

ExchangeOTC: FBDS

Employees1

IPO date2000-03-27

Latest filings

10-Q2025-09-11 8-K2025-08-25 10-Q2025-06-09 10-Q2025-03-05 10-K2025-02-11 10-Q2024-09-06 10-Q2024-06-27 8-K2024-05-08

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.